Browse government tenders, quotations, vacancies and documents across South Africa.
Showing opportunities with a recorded closing date that has not passed. Choose another status to browse historical records.
This addendum clarifies pricing details regarding pack sizes for products under the HP06-2024SVP/02 contract. Suppliers must adhere to the updated price structure as specified.
Suppliers are required to replace the previous version of the contract circular for the supply and delivery of large volume parenterals to the Department of Health with the updated Version 2. This document outlines the revised terms and conditions, including compliance with the General Conditions of Contract and Special Requirements.
An alternative product may be supplied for Olanzapine 10mg tablets, 28/30 tablets, due to temporary stock unavailability by Aurogen (Pty) Ltd. This alternative supply is permitted from August 2026 to 30 October 2026.
Suppliers under the HP08-2026SSP contract must update the National Stock Number (NSN) for two items: Salicylic Acid 5% ointment, 80g (Item 95), and Sodium Picosulphate 10mg with Magnesium Oxide 3.5g/Citric Acid 12g per sachet, 2 sachets (Item 103). The new NSNs are 181892262 and 222001940 respectively.
This opportunity allows qualified suppliers to provide pharmaceutical liquids, alcohol, ether, glycerine, and methylated spirits to the Department of Health and its participating organs of state for the period ending 31 January 2027. The contract is governed by the General Conditions of Contract under Chapter 16A of the Treasury Regulations, with special conditions taking precedence if they conflict.
This opportunity is for suppliers to bid on providing vaccines used in the Expanded Programme on Immunisation (EPI) to the Department of Health and its participating organs of state for the period from 1 January 2027 to 31 December 2029. The contract includes specific vaccines such as DTaP-IPV/Hib/HBV and measles-rubella combination vaccines, with detailed specifications on dosage, presentation, and quality requirements.
This document replaces the previous version of the contract circular for the supply and delivery of semi-solid dosage forms and powders to the Department of Health. It includes updated product specifications and is now the official version for bidders and suppliers.
This opportunity refers to the replacement of the official contract circular related to the vaccine supply agreement. The new version becomes effective from 1 September 2026 and supersedes any previous versions.
This opportunity involves updated terms for the pack size and minimum order quantity for vaccines supplied under the HP16-2027EPI contract. These changes are effective from 18 August 2026 and apply to Biovac as the supplier.
This opportunity is for suppliers to provide pharmaceutical products including drops, aerosols, and inhaled medicines to the Department of Health. The contract period runs from 1 September 2026 to 31 August 2029. Suppliers must comply with updated specifications, including an improved inhaler device with mask for infants.
This opportunity involves the replacement of an existing circular related to the supply and delivery of large volume parenterals, effective from 1 September 2026. It updates procedural or administrative guidance for suppliers.
An alternative brand of Olanzapine 10mg tablets may be supplied by Aurogen (Pty) Ltd to the Department of Health for the period from August 2026 to 30 October 2026 due to stock unavailability of the original brand.
